Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

425 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
What hides behind an intention-to-treat analysis?
Winnock M, Rancinan C, De Ledinghen V, Couzigou P, Chêne G. Winnock M, et al. Among authors: de ledinghen v. Hepatology. 2001 Apr;33(4):1014-5. doi: 10.1053/jhep.2001.0103304le01. Hepatology. 2001. PMID: 11283871 No abstract available.
TT virus infection during chronic hepatitis C.
Trimoulet P, de Lédinghen V, Ekouevi D, Bernard PH, Merel P, Chêne G, Couzigou P, Fleury H. Trimoulet P, et al. Among authors: de ledinghen v. Am J Gastroenterol. 2000 Jul;95(7):1765-9. doi: 10.1111/j.1572-0241.2000.02138.x. Am J Gastroenterol. 2000. PMID: 10925982
[Chronic viral hepatitis C: current therapy and perspectives].
Couzigou P, De Ledinghen V, Foucher J. Couzigou P, et al. Among authors: de ledinghen v. Gastroenterol Clin Biol. 2001 Apr;25(4 Suppl):B135-42. Gastroenterol Clin Biol. 2001. PMID: 11449154 Free article. Review. French. No abstract available.
Daily or three times a week interferon alfa-2b in combination with ribavirin or interferon alone for the treatment of patients with chronic hepatitis C.
de Lédinghen V, Trimoulet P, Winnock M, Foucher J, Bourlière M, Desmorat H, Canva V, Capron D, Lévy S, Mion F, Mannant PR, Chêne G, Fleury H, Couzigou P, Bernard PH; French Multicenter Study Group. de Lédinghen V, et al. J Hepatol. 2002 May;36(5):672-80. doi: 10.1016/s0168-8278(02)00026-0. J Hepatol. 2002. PMID: 11983451 Clinical Trial.
Daily or three times per week interferon alpha-2b in combination with ribavirin or interferon alone for the treatment of patients with chronic hepatitis C not responding to previous interferon alone.
de Lédinghen V, Trimoulet P, Winnock M, Bernard PH, Bourlière M, Portal I, Rémy AJ, Szostak N, Lévy S, Tran A, Abergel A, Chêne G, Fleury H, Couzigou P; French Multicenter Study Group. de Lédinghen V, et al. J Hepatol. 2002 Jun;36(6):819-26. doi: 10.1016/s0168-8278(02)00071-5. J Hepatol. 2002. PMID: 12044534 Clinical Trial.
425 results